Literature DB >> 31756356

Impact of therapeutic lifestyle changes in resistant hypertension.

Cemal Ozemek1, Stephanie Tiwari2, Ahmad Sabbahi3, Salvatore Carbone4, Carl J Lavie5.   

Abstract

Hypertensive individuals are at an increased risk of developing heart disease and stroke. Adopting healthy lifestyles, such as being active on ≥4 days per week, weight-loss in the presence of obesity, consuming a diet rich in fruits and vegetables, and sodium below the recommended threshold, avoiding high alcohol consumption and refraining from smoking have been effective lifestyle therapies to prevent or control stage 1 hypertension (HTN). Among the 1 in 3 Americans who have HTN (systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 80 mmHg), 16% are diagnosed with resistant HTN (RHT). Although there are comparatively fewer studies examining the blood pressure lowering effects of therapeutic lifestyle interventions in patients with resistant HTN, the available literature appears promising. This paper reviews key studies that quantify the blood pressure lowering effects of certain therapeutic lifestyles in patients with RHT and highlights areas needing more attention.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DASH diet; Lifestyle change; Physical activity; Resistant hypertension

Mesh:

Substances:

Year:  2019        PMID: 31756356      PMCID: PMC7257910          DOI: 10.1016/j.pcad.2019.11.012

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  71 in total

1.  The blood flow through muscle during sustained contraction.

Authors:  H Barcroft; J L Millen
Journal:  J Physiol       Date:  1939-11-14       Impact factor: 5.182

2.  The effect of different volumes of acute resistance exercise on elderly individuals with treated hypertension.

Authors:  Luria M L Scher; Eduardo Ferriolli; Julio C Moriguti; Ricardo Scher; Nereida K C Lima
Journal:  J Strength Cond Res       Date:  2011-04       Impact factor: 3.775

Review 3.  Precision in Promoting Physical Activity and Exercise With the Overarching Goal of Moving More.

Authors:  Cemal Ozemek; Ross Arena
Journal:  Prog Cardiovasc Dis       Date:  2018-12-07       Impact factor: 8.194

4.  Effect of the physical activity program on the treatment of resistant hypertension in primary care.

Authors:  Piotr J Kruk; Michał Nowicki
Journal:  Prim Health Care Res Dev       Date:  2018-03-22       Impact factor: 1.458

5.  Effects of short-term heated water-based exercise training on systemic blood pressure in patients with resistant hypertension: a pilot study.

Authors:  Guilherme V Guimarães; Lais G B Cruz; Aline C Tavares; Egidio L Dorea; Miguel M Fernandes-Silva; Edimar A Bocchi
Journal:  Blood Press Monit       Date:  2013-12       Impact factor: 1.444

6.  Effect of 4 weeks of aerobic or resistance exercise training on arterial stiffness, blood flow and blood pressure in pre- and stage-1 hypertensives.

Authors:  S R Collier; J A Kanaley; R Carhart; V Frechette; M M Tobin; A K Hall; A N Luckenbaugh; B Fernhall
Journal:  J Hum Hypertens       Date:  2008-10       Impact factor: 3.012

7.  Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension: the Reasons for Geographic and Racial Differences in Stroke study.

Authors:  Keith M Diaz; John N Booth; David A Calhoun; Marguerite R Irvin; George Howard; Monika M Safford; Paul Muntner; Daichi Shimbo
Journal:  Hypertension       Date:  2014-06-09       Impact factor: 10.190

8.  The contributions of unhealthy lifestyle factors to apparent resistant hypertension: findings from the Reasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Authors:  Daichi Shimbo; Emily B Levitan; John N Booth; David A Calhoun; Suzanne E Judd; Daniel T Lackland; Monika M Safford; Suzanne Oparil; Paul Muntner
Journal:  J Hypertens       Date:  2013-02       Impact factor: 4.844

9.  Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial.

Authors:  Rajiv Agarwal; Patrick Rossignol; Alain Romero; Dahlia Garza; Martha R Mayo; Suzette Warren; Jia Ma; William B White; Bryan Williams
Journal:  Lancet       Date:  2019-09-15       Impact factor: 79.321

10.  Sixteen weeks of resistance training can decrease the risk of metabolic syndrome in healthy postmenopausal women.

Authors:  Miguel Soares Conceição; Valéria Bonganha; Felipe Cassaro Vechin; Ricardo Paes de Barros Berton; Manoel Emílio Lixandrão; Felipe Romano Damas Nogueira; Giovana Vergínia de Souza; Mara Patricia Traina Chacon-Mikahil; Cleiton Augusto Libardi
Journal:  Clin Interv Aging       Date:  2013-09-16       Impact factor: 4.458

View more
  12 in total

Review 1.  Lifestyle interventions for the prevention and treatment of hypertension.

Authors:  Pedro L Valenzuela; Pedro Carrera-Bastos; Beatriz G Gálvez; Gema Ruiz-Hurtado; José M Ordovas; Luis M Ruilope; Alejandro Lucia
Journal:  Nat Rev Cardiol       Date:  2020-10-09       Impact factor: 32.419

2.  Underuse of lifestyle recommendations in hypertension management in France: The Esteban study.

Authors:  Juliette Vay-Demouy; Hélène Lelong; Pauline Neudorff; Amélie Gabet; Clémence Grave; Jacques Blacher; Valérie Olié
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-09-30       Impact factor: 2.885

3.  2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

Authors:  Tzung-Dau Wang; Chern-En Chiang; Ting-Hsing Chao; Hao-Min Cheng; Yen-Wen Wu; Yih-Jer Wu; Yen-Hung Lin; Michael Yu-Chih Chen; Kwo-Chang Ueng; Wei-Ting Chang; Ying-Hsiang Lee; Yu-Chen Wang; Pao-Hsien Chu; Tzu-Fan Chao; Hsien-Li Kao; Charles Jia-Yin Hou; Tsung-Hsien Lin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

4.  The Lifestyle Profile of Individuals with Cardiovascular and Endocrine Diseases in Cyprus: A Hierarchical, Classification Analysis.

Authors:  Maria Kyprianidou; Demosthenes Panagiotakos; Konstantinos C Makris; Maria Kambanaros; Costas A Christophi; Konstantinos Giannakou
Journal:  Nutrients       Date:  2022-04-08       Impact factor: 6.706

Review 5.  Nonpharmacological Management of Resistant Hypertension.

Authors:  Ahmad Sabbahi; Richard Severin; Deepika Laddu; James E Sharman; Ross Arena; Cemal Ozemek
Journal:  Curr Cardiol Rep       Date:  2021-10-01       Impact factor: 3.955

Review 6.  Does Exercise Improve the Cardiometabolic Risk Profile of Patients with Obesity After Bariatric Surgery? A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Giorjines Boppre; Florêncio Diniz-Sousa; Lucas Veras; José Oliveira; Hélder Fonseca
Journal:  Obes Surg       Date:  2022-03-24       Impact factor: 3.479

7.  Exercise-Induced Changes in Bioactive Lipids Might Serve as Potential Predictors of Post-Exercise Hypotension. A Pilot Study in Healthy Volunteers.

Authors:  Miriam C Wolters; Julia Schmetzer; Christine V Möser; Lisa Hahnefeld; Carlo Angioni; Dominique Thomas; Nerea Ferreirós; Gerd Geisslinger; Ellen Niederberger
Journal:  Cells       Date:  2020-09-16       Impact factor: 6.600

Review 8.  Interplay between baroreflex sensitivity, obesity and related cardiometabolic risk factors (Review).

Authors:  Sofia K Konstantinidou; Georgia Argyrakopoulou; Nicholas Tentolouris; Vangelis Karalis; Alexander Kokkinos
Journal:  Exp Ther Med       Date:  2021-11-23       Impact factor: 2.447

Review 9.  Skipping Breakfast Is Associated with Hypertension in Adults: A Meta-Analysis.

Authors:  Zishuo Li; Hongli Li; Qin Xu; Yanli Long
Journal:  Int J Hypertens       Date:  2022-03-03       Impact factor: 2.420

10.  Effects of Alcohol Consumption and Smoking on the Onset of Hypertension in a Long-Term Longitudinal Study in a Male Workers' Cohort.

Authors:  Tamotsu Nagao; Kazuhiro Nogawa; Koichi Sakata; Hideki Morimoto; Kotaro Morita; Yuka Watanabe; Yasushi Suwazono
Journal:  Int J Environ Res Public Health       Date:  2021-11-10       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.